[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"respiratory-syndrome-acute-severe\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:respiratory-syndrome-acute-severe":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":26,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100646033","clinical-multimodal-surveillance-of-respiratory-syndrome-pathogens-100646033",false,"NCT07694648","Clinical Multimodal Surveillance of Respiratory Syndrome Pathogens","Clinical Multimodal Early Warning Surveillance of Respiratory Syndrome Pathogens and Construction and Application of Prevention and Control Measures","Inclusion Criteria:\n\n* Patients with respiratory syndrome: Eligible patients are those diagnosed with respiratory syndrome based on the predefined data dictionary and the following ICD-10 (International Statistical Classification of Diseases, 10th Revision) diagnosis codes: R05, R50, J00, J01, J02, J03, J04, J06, J07, J08, J09, J10, J11, J12, J13, J14, J15, J16, J17, J18, J20, J21, J98.414, and J98.802.\n* Patients with respiratory syndrome: Eligible patients are identified using the following search criteria. Patients meeting any one of the following criteria should be included:\n\n  1. Medical history (History of Present Illness): Positive test result for a respiratory syndrome-related pathogen.\n  2. Laboratory testing: Positive test result for a respiratory syndrome-related pathogen.\n  3. Medication: Receipt of any of the following antiviral agents:\n\n     Nirmatrelvir\u002FRitonavir Leritrelvir Xiannuotewei\u002FRitonavir Molnupiravir Azvudine Deuremidevir\n  4. Diagnosis: Diagnosis containing the term \"respiratory tract infection.\"\n\nExclusion Criteria:\n\n* Participants who may compromise the study results: Patients who are unable to provide a specimen or whose specimen volume is insufficient for laboratory testing.\n* Participants who are unable to comply with study procedures.","ALL",{"count":18,"type":19},2398,"ESTIMATED","OBSERVATIONAL","This nationwide, multicenter observational study will establish and improve a hospital-based clinical surveillance and early warning system for respiratory syndrome pathogens. Clinical data and biospecimens generated during routine care will be collected from participating medical institutions every two weeks to monitor pathogen trends, support risk assessment, and provide evidence for prevention and control measures.",[23,24,25],"Respiratory Tract Infections (RTI)","Respiratory Syndrome, Acute, Severe","Acute Respiratory Infections (ARIs)",[27,28,29,30,31,32,33,34],"Respiratory syndrome","respiratory pathogens","clinical surveillance","early warning","multiplex PCR","metagenomic next-generation sequencing","multi-omics","nationwide multicenter study","RECRUITING","2026-07-03",{"date":38,"type":39},"2026-07-10","ACTUAL",{"date":41,"type":39},"2025-09-01",{"date":43,"type":19},"2028-09-30",{"name":45,"class":46},"Huashan Hospital","OTHER",31]